Immunopathogenesis of chronic hepatitis B

World Journal of Gastroenterology

Volumn 20, Issue 39, 2014, Pages 14156-14171

  Balmasova, Irina P ^a,b   Yushchuk, Nikolay D ^a   Mynbaev, Ospan A ^a,b,c   Alla, Nageswara R ^d   Malova, Elena S ^e   Shi, Zhongjie ^f   Gao, Chang Lu ^g  

^a A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^c MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Limited Liability Medical Company Hepatologist   (Russian Federation)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis B; Immunopathogenesis

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADAPTIVE IMMUNITY; ANIMAL; DRUG DESIGN; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; VIROLOGY; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIVIRAL AGENTS; DRUG DESIGN; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; VIRUS REPLICATION;

EID: 84925857603     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i39.14156     Document Type: Article

References (150)

1. Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol 2010; 116: 147-159 [PMID: 20567182 DOI: 10.1097/AOG.0b013e3181e45951]
2. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-tochild transmission-a meta-analysis. Int J Infect Dis 2010; 14: e622-e634 [PMID: 20106694 DOI: 10.1016/j.ijid.2009.09.008]
3. Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, Alexander G, Finney H, Lawson A, Plunkett FJ, Bertoletti A, Akbar AN, Maini MK. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med 2008; 205: 2111-2124 [PMID: 18695005 DOI: 10.1084/jem.20072076]
4. Janssen HL, van Zonneveld M, Schalm SW. Hepatitis B. N Engl J Med 2004; 350: 2719-2720 [PMID: 15215493 DOI: 10.1056/NEJM200406243502620]
5. Shi Z, Li X, Yang Y, Ma L, Schreiber A. Obstetrical management of fulminant viral hepatitis in late pregnancy. Reproductive Sys Sexual Disord 2012; 1: 102 [DOI: 10.4172/2161-038X.1000102]
6. Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, Li M, Ma L. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis 2012; 31: 2673-2678 [PMID: 22569645]
7. Deng L, Li X, Shi Z, Jiang P, Chen D, Ma L. Maternal and perinatal outcome in cases of fulminant viral hepatitis in late pregnancy. Int J Gynaecol Obstet 2012; 119: 145-148 [PMID: 22947378 DOI: 10.1016/j.ijgo.2012.05.041]
8. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009; 49: S13-S21 [PMID: 19399811 DOI: 10.1002/hep.22881]
9. Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antivir Ther 2010; 15 Suppl 3: 25-33 [PMID: 21041901 DOI: 10.3851/IMP1621]
10. Baumert TF, Thimme R, von Weizsäcker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007; 13: 82-90 [PMID: 17206757]
11. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68 [PMID: 10704474 DOI: 10.1128/MMBR.64.1.51-68.2000]
12. Gerlich WH, Robinson WS. Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand. Cell 1980; 21: 801-809 [PMID: 7438207 DOI: 10.1016/0092-8674(80)90443-2]
13. Molnar-Kimber KL, Summers J, Taylor JM, Mason WS. Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J Virol 1983; 45: 165-172 [PMID: 6823008]
14. Martin K, Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 1991; 67: 117-130 [PMID: 1913813 DOI: 10.1016/0092-8674(91)90576-K]
15. Ganem D, Schneider RJ. Hepadnaviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 2923-2969
16. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009; 51: 581-592 [PMID: 19616338 DOI: 10.1016/j.jhep.2009.05.022]
17. Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol 2007; 13: 48-64 [PMID: 17206754]
18. Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. Int Immunol 2012; 24: 97-106 [PMID: 22190574 DOI: 10.1093/intimm/dxr104]
19. Hoffmann J, Boehm C, Himmelsbach K, Donnerhak C, Roettger H, Weiss TS, Ploen D, Hildt E. Identification of α-taxilin as an essential factor for the life cycle of hepatitis B virus. J Hepatol 2013; 59: 934-941 [PMID: 23816704 DOI: 10.1016/j.jhep.2013.06.020]
20. Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 2007; 11: 685-706, vii [PMID: 17981225]
21. Bonino F, Brunetto MR. Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview. J Hepatol 2003; 39 Suppl 1: S160-S163 [PMID: 14708696]
22. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002; 36: 263-270 [PMID: 11830339]
23. Norder H, Couroucé AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 1992; 73 (Pt 12): 3141-3145 [PMID: 1469353 DOI: 10.1099/0022-1317-73-12-3141]
24. Roman S, Panduro A. HBV endemicity in Mexico is associated with HBV genotypes H and G. World J Gastroenterol 2013; 19: 5446-5453 [PMID: 24023487 DOI: 10.3748/wjg.v19.i33.5446]
25. Domingo E, Sheldon J, Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev 2012; 76: 159-216 [PMID: 22688811 DOI: 10.1128/MMBR.05023-11]
26. Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol 2011; 17: 1927-1938 [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927]
27. Wong DK, Huang FY, Lai CL, Poon RT, Seto WK, Fung J, Hung IF, Yuen MF. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 2011; 54: 829-836 [PMID: 21809355 DOI: 10.1002/hep.24551]
28. Deng L, Tang H. Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites. Hepatol Res 2011; 41: 1017-1024 [PMID: 21917087 DOI: 10.1111/j.1872-034X.2011.00873.x]
29. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004; 101: 6669-6674 [PMID: 15100412 DOI: 10.1073/pnas.0401771101]
30. Chen GY, He JQ, Lv GC, Li MW, Xu CH, Fan WW, Chen Z. [Involvement of TRAIL up-regulation of CD4+, CD8+ T cells in liver injury in chronic hepatitis B]. Zhonghua Ganzangbing Zazhi 2004; 12: 284-286 [PMID: 15161504]
31. Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15: 3099-3105 [PMID: 19575488]
32. Ratnam D, Visvanathan K. New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response. Hepatol Int 2008; 2: 12-18 [PMID: 19669294 DOI: 10.1007/s12072-008-9067-0]
33. Malova ES, Balmasova IP, Iuschuk ND, Shmeleva EV, Eremina OF. [Association between expression of lectin type receptors by natural killers and intensity of liver fibrosis during chronic hepatitis C]. Zh Mikrobiol Epidemiol Immunobiol 2010; (6): 48-52 [PMID: 21381377]
34. You J, Sriplung H, Geater A, Chongsuvivatwong V, Zhuang L, Chen HY, Yu L, Tang BZ, Huang JH. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B. World J Gastroenterol 2008; 14: 1112-1119 [PMID: 18286696 DOI: 10.3748/wjg.14.1112]
35. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 2004; 24: 637-646 [PMID: 15622448]
36. Frelin L, Wahlström T, Tucker AE, Jones J, Hughes J, Lee BO, Billaud JN, Peters C, Whitacre D, Peterson D, Milich DR. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol 2009; 83: 1379-1392 [PMID: 19004949 DOI: 10.1128/JVI.01902-08]
37. Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 2008; 123: 57-65 [PMID: 17764450 DOI: 10.1111/j.1365-2567.2007.02691.x]
38. Feng IC, Koay LB, Sheu MJ, Kuo HT, Sun CS, Lee C, Chuang WL, Liao SK, Wang SL, Tang LY, Cheng CJ, Tsai SL. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection. J Biomed Sci 2007; 14: 43-57 [PMID: 17109186]
39. Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. J Med Virol 2004; 72: 545-550 [PMID: 14981756 DOI: 10.1002/jmv.20024]
40. Roseman AM, Borschukova O, Berriman JA, Wynne SA, Pumpens P, Crowther RA. Structures of hepatitis B virus cores presenting a model epitope and their complexes with antibodies. J Mol Biol 2012; 423: 63-78 [PMID: 22750730 DOI: 10.1016/j.jmb.2012.06.032]
41. van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG, Kwekkeboom J, Janssen HL. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004; 40: 738-746 [PMID: 15349914 DOI: 10.1002/hep.20366]
42. Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 1986; 234: 1398-1401 [PMID: 3491425 DOI: 10.1126/science.3491425]
43. Fehr T, Skrastina D, Pumpens P, Zinkernagel RM. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci USA 1998; 95: 9477-9481 [PMID: 9689105]
44. Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, Pittaluga S, Boon D, Yu C, Engle RE, Haas M, Simon R, Purcell RH, Zamboni F. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci USA 2010; 107: 8766-8771 [PMID: 20421498 DOI: 10.1073/pnas.1003854107]
45. Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. J Viral Hepat 2010; 17 Suppl 1: 34-43 [PMID: 20586932 DOI: 10.1111/j.1365-2893.2010.01269.x]
46. Li L, Liu M, Cheng LW, Gao XY, Fu JJ, Kong G, Feng X, Pan XC. HBcAg-specific IL-21-producing CD4+ T cells are associated with relative viral control in patients with chronic hepatitis B. Scand J Immunol 2013; 78: 439-446 [PMID: 23957859 DOI: 10.1111/sji.12099]
47. Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice. Vaccine 2013; 31: 1197-1203 [PMID: 23306359 DOI: 10.1016/j.vaccine.2012.12.074]
48. Iwamura K. Laparoscopic an histologic abnormalities of the liver in chronic asymptomatic hepatitis B surface antigen carriers. Tokai J Exp Clin Med 1981; 6: 385-391 [PMID: 7324079]
49. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38: 1075-1086 [PMID: 14578844 DOI: 10.1053/jhep.2003.50453]
50. Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005; 79: 3016-3027 [PMID: 15709022 DOI: 10.1128/JVI.79.5.3016-3027.2005]
51. Chen MT, Billaud JN, Sällberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 2004; 101: 14913-14918 [PMID: 15469922 DOI: 10.1073/pnas.0406282101]
52. Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41: 771-778 [PMID: 15791617 DOI: 10.1002/hep.20649]
53. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 2006; 3: 97-106 [PMID: 16696896]
54. Malmström S, Larsson SB, Hannoun C, Lindh M. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load - down-regulated transcription of PgRNA has limited impact. PLoS One 2012; 7: e36349 [PMID: 22911677 DOI: 10.1371/journal.pone.0036349]
55. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis 2005; 25 Suppl 1: 3-8 [PMID: 16103976 DOI: 10.1055/s-2005-915644]
56. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J 2005; 2: 82 [PMID: 16191199 DOI: 10.1186/1743-422X-2-82]
57. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, Wang LY, Su J, Sun CA, Liaw YF, Chen CJ. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010; 138: 1747-1754 [PMID: 20114048 DOI: 10.1053/j.gastro.2010.01.042]
58. Tan AT, Loggi E, Boni C, Chia A, Gehring AJ, Sastry KS, Goh V, Fisicaro P, Andreone P, Brander C, Lim SG, Ferrari C, Bihl F, Bertoletti A. Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J Virol 2008; 82: 10986-10997 [PMID: 18799575 DOI: 10.1128/JVI.01124-08]
59. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P, Das A, Lopes AR, Borrow P, Williams K, Humphreys E, Afford S, Adams DH, Bertoletti A, Maini MK. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204: 667-680 [PMID: 17353365 DOI: 10.1084/jem.20061287]
60. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010; 29: 2309-2324 [PMID: 20228847 DOI: 10.1038/onc.2010.36]
61. Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K, Yamamura K. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 1989; 86: 207-211 [PMID: 2911569]
62. Block TM, Mehta AS, Blumberg BS, Dwek RA. Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity? DNA Cell Biol 2006; 25: 165-170 [PMID: 16569195]
63. Hyodo N, Nakamura I, Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol 2004; 135: 462-466 [PMID: 15008979 DOI: 10.1111/j.1365-2249.2003.02376.x]
64. McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 2000; 74: 2255-2264 [PMID: 10666256 DOI: 10.1128/JVI.74.5.2255-2264.2000]
65. Guan SH, Lu M, Grünewald P, Roggendorf M, Gerken G, Schlaak JF. Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment. World J Gastroenterol 2007; 13: 228-235 [PMID: 17226901]
66. Chen J, Wu M, Zhang X, Zhang W, Zhang Z, Chen L, He J, Zheng Y, Chen C, Wang F, Hu Y, Zhou X, Wang C, Xu Y, Lu M, Yuan Z. Hepatitis B virus polymerase impairs interferon-β-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ. Hepatology 2013; 57: 470-482 [PMID: 22996189 DOI: 10.1002/hep.26064]
67. Yamazaki S, Inaba K, Tarbell KV, Steinman RM. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006; 212: 314-329 [PMID: 16903923 DOI: 10.1111/j.0105-2896.2006.00422.x]
68. Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68-76 [PMID: 12477811 DOI: 10.1128/JVI.77.1.68-76.2003]
69. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci USA 2004; 101: 2129-2134 [PMID: 14764900 DOI: 10.1073/pnas.0308478100]
70. Decalf J, Fernandes S, Longman R, Ahloulay M, Audat F, Lefrerre F, Rice CM, Pol S, Albert ML. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients. J Exp Med 2007; 204: 2423-2437 [PMID: 17893202 DOI: 10.1084/jem.20070814]
71. Ito T, Kanzler H, Duramad O, Cao W, Liu YJ. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 2006; 107: 2423-2431 [PMID: 16293610 DOI: 10.1182/blood-2005-07-2709]
72. Li K, Chen Z, Kato N, Gale M, Lemon SM. Distinct poly(I-C) and virus-activated signaling pathways leading to interfer-on-beta production in hepatocytes. J Biol Chem 2005; 280: 16739-16747 [PMID: 15737993 DOI: 10.1074/jbc.M414139200]
73. Sitia G, Isogawa M, Iannacone M, Campbell IL, Chisari FV, Guidotti LG. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest 2004; 113: 1158-1167 [PMID: 15085195]
74. Kakimi K, Lane TE, Chisari FV, Guidotti LG. Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 2001; 167: 6701-6705 [PMID: 11739482]
75. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, Vogel SN. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999; 163: 1537-1544 [PMID: 10415057]
76. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, Adachi K, Futatsugi S, Kuida K, Takeuchi O, Okamura H, Fujimoto J, Akira S, Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol 2001; 166: 2651-2657 [PMID: 11160328]
77. Dolganiuc A, Norkina O, Kodys K, Catalano D, Bakis G, Marshall C, Mandrekar P, Szabo G. Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 2007; 133: 1627-1636 [PMID: 17916356 DOI: 10.1053/j.gastro.2007.08.003]
78. Li N, Li Q, Qian Z, Zhang Y, Chen M, Shi G. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage. Biochem Biophys Res Commun 2009; 390: 630-635 [PMID: 19833099 DOI: 10.1016/j.bbrc.2009.10.018]
79. Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin Vaccine Immunol 2006; 13: 972-974 [PMID: 16894001 DOI: 10.1128/CVI.00396-05]
80. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210 [PMID: 18161745 DOI: 10.1002/path.2277]
81. Shi F, Zhang JY, Zeng Z, Tien P, Wang FS. Skewed ratios between CD3(+) T cells and monocytes are associated with poor prognosis in patients with HBV-related acute-onchronic liver failure. Biochem Biophys Res Commun 2010; 402: 30-36 [PMID: 20883666 DOI: 10.1016/j.bbrc.2010.09.096]
82. Ma YJ, He M, Han JA, Yang L, Ji XY. A clinical study of HB-sAg- activated dendritic cells and cytokine-induced killer cells during the treatment for chronic hepatitis B. Scand J Immunol 2013; 78: 387-393 [PMID: 23841728 DOI: 10.1111/sji.12097]
83. Woltman AM, Ter Borg MJ, Binda RS, Sprengers D, von Blomberg BM, Scheper RJ, Hayashi K, Nishi N, Boonstra A, van der Molen R, Janssen HL. Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antivir Ther 2009; 14: 809-818 [PMID: 19812443 DOI: 10.3851/1295]
84. Liu QF, Zhang Z, Yao JX, Shi M, Zhang H, Mao YL, Wang FS. [Identification of circulating plasmacytoid dendritic cells in chronic HBV-infected patients]. Zhonghua Ganzangbing Zazhi 2006; 14: 725-728 [PMID: 17064462]
85. Zhang Z, Zou ZS, Fu JL, Cai L, Jin L, Liu YJ, Wang FS. Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 2008; 49: 396-406 [PMID: 18644645 DOI: 10.1016/j.jhep.2008.05.017]
86. Op den Brouw ML, Binda RS, van Roosmalen MH, Protzer U, Janssen HL, van der Molen RG, Woltman AM. Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus. Immunology 2009; 126: 280-289 [PMID: 18624732 DOI: 10.1111/j.1365-2567.2008.02896.x]
87. Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003; 109: 487-495 [PMID: 12871214 DOI: 10.1046/j.1365-2567.2003.01699.x]
88. Sepiashvili RI, Balmasova IP, Kabanova EV, Malova ES, Slavianskaia TA. [Hepatitis B virus: biology, immunopathogenesis, NK/NKT system in viral persistence]. Zh Mikrobiol Epidemiol Immunobiol 2006; (6): 76-83 [PMID: 17163145]
89. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91 [PMID: 11244031]
90. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L. NK cells at the interface between innate and adaptive immunity. Cell Death Differ 2008; 15: 226-233 [PMID: 17541426 DOI: 10.1038/sj.cdd.4402170]
91. Sato K, Hida S, Takayanagi H, Yokochi T, Kayagaki N, Takeda K, Yagita H, Okumura K, Tanaka N, Taniguchi T, Ogasawara K. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur J Immunol 2001; 31: 3138-3146 [PMID: 11745330 DOI: 10.1002/1521-4141(200111)]
92. Chen Y, Sun R, Jiang W, Wei H, Tian Z. Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I: C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol 2007; 47: 183-190 [PMID: 17448568 DOI: 10.1016/j.jhep.2007.02.020]
93. Chen Y, Wei H, Sun R, Dong Z, Zhang J, Tian Z. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 2007; 46: 706-715 [PMID: 17626270 DOI: 10.1002/hep.21872]
94. Paladino N, Flores AC, Marcos CY, Fainboim H, Theiler G, Arruvito L, Williams F, Middleton D, Fainboim L. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007; 69 Suppl 1: 109-111 [PMID: 17445180 DOI: 10.1111/j.1399-0039.2006.762-7.x]
95. Kanto T. Virus associated innate immunity in liver. Front Biosci 2008; 13: 6183-6192 [PMID: 18508652]
96. Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, Harris NL, Junt T, Odermatt B, Clavien PA, Pircher H, Akira S, Hengartner H, Zinkernagel RM. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 2006; 116: 2456-2463 [PMID: 16955143 DOI: 10.1172/JCI28349]
97. Rauch A, Laird R, McKinnon E, Telenti A, Furrer H, Weber R, Smillie D, Gaudieri S. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 2007; 69 Suppl 1: 237-240 [PMID: 17445209 DOI: 10.1111/j.1399-0039.2006.773-4.x]
98. Kahraman A, Fingas CD, Syn WK, Gerken G, Canbay A. Role of stress-induced NKG2D ligands in liver diseases. Liver Int 2012; 32: 370-382 [PMID: 22097967 DOI: 10.1111/j.1478-3231.2011.02608.x]
99. Jinushi M, Takehara T, Tatsumi T, Yamaguchi S, Sakamori R, Hiramatsu N, Kanto T, Ohkawa K, Hayashi N. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 2007; 120: 73-82 [PMID: 17052247 DOI: 10.1111/j.1365-2567.2006.02479.x]
100. Stoop JN, Woltman AM, Biesta PJ, Kusters JG, Kuipers EJ, Janssen HL, van der Molen RG. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response. Hepatology 2007; 46: 699-705 [PMID: 17654744 DOI: 10.1002/hep.21761]
101. Lang PA, Lang KS, Xu HC, Grusdat M, Parish IA, Recher M, Elford AR, Dhanji S, Shaabani N, Tran CW, Dissanayake D, Rahbar R, Ghazarian M, Brüstle A, Fine J, Chen P, Weaver CT, Klose C, Diefenbach A, Häussinger D, Carlyle JR, Kaech SM, Mak TW, Ohashi PS. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci USA 2012; 109: 1210-1215 [PMID: 22167808 DOI: 10.1073/pnas.1118834109]
102. Trobonjaca Z, Leithäuser F, Möller P, Schirmbeck R, Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol 2001; 167: 1413-1422 [PMID: 11466360]
103. Hammond KJ, Pelikan SB, Crowe NY, Randle-Barrett E, Nakayama T, Taniguchi M, Smyth MJ, van Driel IR, Scollay R, Baxter AG, Godfrey DI. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999; 29: 3768-3781 [PMID: 10556834]
104. Kenna T, Golden-Mason L, Porcelli SA, Koezuka Y, Hegarty JE, O'Farrelly C, Doherty DG. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J Immunol 2003; 171: 1775-1779 [PMID: 12902477]
105. Weng PJ, Ying H, Hong LZ, Zhou WH, Hu YR, Xu CH. [An analysis of CD3+CD56+ lymphocytes and their subsets in the peripheral blood of patients with chronic hepatitis B]. Zhonghua Ganzangbing Zazhi 2008; 16: 654-656 [PMID: 18822203]
106. Nemeth E, Baird AW, O'Farrelly C. Microanatomy of the liver immune system. Semin Immunopathol 2009; 31: 333-343 [PMID: 19639317 DOI: 10.1007/s00281-009-0173-4]
107. Wang FS, Xing LH, Liu MX, Zhu CL, Liu HG, Wang HF, Lei ZY. Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 2001; 7: 537-541 [PMID: 11819824]
108. Xu Y, Hu Y, Shi B, Zhang X, Wang J, Zhang Z, Shen F, Zhang Q, Sun S, Yuan Z. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009; 46: 2640-2646 [PMID: 19501403 DOI: 10.1016/j.molimm.2009.04.031]
109. Perrin-Cocon L, Agaugué S, Diaz O, Vanbervliet B, Dollet S, Guironnet-Paquet A, André P, Lotteau V. Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS One 2008; 3: e2260 [PMID: 18509450 DOI: 10.1371/journal.pone.0002260]
110. Chen X, Liu H, Tang Z, Yu Y, Zang G. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide. Acta Biochim Biophys Sin (Shanghai) 2013; 45: 203-212 [PMID: 23299079 DOI: 10.1093/abbs/gms116]
111. Zhang L, Zhao Y. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J Cell Physiol 2007; 211: 590-597 [PMID: 17311282 DOI: 10.1002/jcp.21001]
112. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007; 445: 931-935 [PMID: 17237765 DOI: 10.1038/nature05478]
113. Manigold T, Racanelli V. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 7: 804-813 [PMID: 18045563 DOI: 10.1016/S1473-3099(07)70289-X]
114. Guo JC, Bao JF, Chen QW, Li XO, Shi JP, Lou GQ, Shi WZ, Xun YH. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B]. Zhonghua Shiyan He Linchuangbingduxue Zazhi 2008; 22: 354-357 [PMID: 19469173]
115. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176: 6752-6761 [PMID: 16709834]
116. Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-747 [PMID: 16785573]
117. Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, Janssen HL, van der Molen RG, Boonstra A. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 2008; 129: 419-427 [PMID: 18823821 DOI: 10.1016/j.clim.2008.07.029]
118. Aalaei-Andabili SH, Alavian SM. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine 2012; 30: 5595-5602 [PMID: 22781305 DOI: 10.1016/j.vaccine.2012.06.063]
119. Shimizu Y. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World J Gastroenterol 2012; 18: 2443-2451 [PMID: 22654441 DOI: 10.3748/wjg.v18.i20.2443]
120. Fife BT, Pauken KE. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Ann N Y Acad Sci 2011; 1217: 45-59 [PMID: 21276005 DOI: 10.1111/j.1749-6632.2010.05919.x]
121. Chen J, Wang XM, Wu XJ, Wang Y, Zhao H, Shen B, Wang GQ. Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B. Inflamm Res 2011; 60: 47-53 [PMID: 20661763 DOI: 10.1007/s00011-010-0233-1]
122. Peng G, Luo B, Li J, Zhao D, Wu W, Chen F, Chen Z. Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients. J Clin Immunol 2011; 31: 195-204 [PMID: 21120686 DOI: 10.1007/s10875-010-9483-5]
123. Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang JP, Bai XF. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection. Viral Immunol 2010; 23: 63-70 [PMID: 20121403 DOI: 10.1089/vim.2009.0061]
124. Reignat S, Webster GJ, Brown D, Ogg GS, King A, Seneviratne SL, Dusheiko G, Williams R, Maini MK, Bertoletti A. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002; 195: 1089-1101 [PMID: 11994415 DOI: 10.1084/jem.20011723].]
125. Bertoletti A, D'Elios MM, Boni C, De Carli M, Zignego AL, Durazzo M, Missale G, Penna A, Fiaccadori F, Del Prete G, Ferrari C. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997; 112: 193-199 [PMID: 8978359]
126. Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81-91 [PMID: 19842207 DOI: 10.1002/hep.23273]
127. Zhang GL, Xie DY, Ye YN, Lin CS, Zhang XH, Zheng YB, Huang ZL, Peng L, Gao ZL. High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV. Liver Int 2014; 34: 266-273 [PMID: 23890319 DOI: 10.1111/liv.12268]
128. Zhang GL, Xie DY, Lin BL, Xie C, Ye YN, Peng L, Zhang SQ, Zhang YF, Lai Q, Zhu JY, Zhang Y, Huang YS, Hu ZX, Gao ZL. Imbalance of interleukin-17-producing CD4 T cells/ regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acute-on-chronic liver failure. J Gastroenterol Hepatol 2013; 28: 513-521 [PMID: 23215950 DOI: 10.1111/jgh.12082]
129. Kitani A, Xu L. Regulatory T cells and the induction of IL-17. Mucosal Immunol 2008; 1 Suppl 1: S43-S46 [PMID: 19079228 DOI: 10.1038/mi.2008.51]
130. Wang S, Zhang X, Ju Y, Zhao B, Yan X, Hu J, Shi L, Yang L, Ma Z, Chen L, Liu Y, Duan Z, Chen X, Meng S. MicroRNA-146a feedback suppresses T cell immune function by targeting Stat1 in patients with chronic hepatitis B. J Immunol 2013; 191: 293-301 [PMID: 23698745 DOI: 10.4049/jimmunol.1202100]
131. Zhang Z, Zhang JY, Wang LF, Wang FS. Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 2012; 27: 223-230 [PMID: 22004062 DOI: 10.1111/j.1440-1746.2011.06940.x]
132. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002; 169: 5188-5195 [PMID: 12391236]
133. Kim JY, Song EH, Lee HJ, Oh YK, Choi KH, Yu DY, Park SI, Seong JK, Kim WH. HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways. J Mol Biol 2010; 397: 917-931 [PMID: 20156456 DOI: 10.1016/j.jmb.2010.02.016]
134. Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma. Medicine (Baltimore) 2009; 88: 349-357 [PMID: 19910749 DOI: 10.1097/MD.0b013e3181c10477]
135. Baniyash M. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol 2004; 4: 675-687 [PMID: 15343367]
136. Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008; 134: 1470-1481 [PMID: 18355815 DOI: 10.1053/j.gastro.2008.02.017]
137. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005; 5: 641-654 [PMID: 16056256]
138. Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C. Altered serum N-glycomics in chronic hepatitis B patients. Liver Int 2010; 30: 259-267 [PMID: 19951379 DOI: 10.1111/j.1478-3231.2009.02170.x]
139. Tavakoli S, Schwerin W, Rohwer A, Hoffmann S, Weyer S, Weth R, Meisel H, Diepolder H, Geissler M, Galle PR, Löhr HF, Böcher WO. Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 2004; 85: 2829-2836 [PMID: 15448344 DOI: 10.1099/vir.0.80143-0]
140. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47: 451-460 [PMID: 3768961 DOI: 10.1016/0092-8674(86)90602-1]
141. Milich DR, Peterson DL, Schödel F, Jones JE, Hughes JL. Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol 1995; 69: 2776-2785 [PMID: 7535865]
142. Lu Y, Tan TL, Zhang J, Chen WN. Cellular apoptosis induced by replication of hepatitis B virus: possible link between viral genotype and clinical outcome. Virol J 2007; 4: 117 [PMID: 17973991 DOI: 10.1186/1743-422X-4-117]
143. Xiong SQ, Lin BL, Gao X, Tang H, Wu CY. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers. Int Immunopharmacol 2007; 7: 578-587 [PMID: 17386405]
144. Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G, Bertoletti A, Ferrari C. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007; 81: 4215-4225 [PMID: 17287266 DOI: 10.1128/JVI.02844-06]
145. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, Gogos CA. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol 2013; 4: 24-27 [PMID: 23596552 DOI: 10.4291/wjgp.v4.i1.24]
146. Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2011; 54: 209-218 [PMID: 21095036 DOI: 10.1016/j.jhep.2010.07.009]
147. Guo S, Yang C, Mei F, Wu S, Luo N, Fei L, Chen Y, Wu Y. Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection. Clin Immunol 2010; 136: 282-291 [PMID: 20399148 DOI: 10.1016/j.clim.2010.03.007]
148. van der Molen RG, Sprengers D, Biesta PJ, Kusters JG, Janssen HL. Favorable effect of adefovir on the number and functionality of myeloid dendritic cells of patients with chronic HBV. Hepatology 2006; 44: 907-914 [PMID: 17006907]
149. Xu N, Yao HP, Lv GC, Chen Z. Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B. Inflamm Res 2012; 61: 997-1004 [PMID: 22684144 DOI: 10.1007/s00011-012-0493-z]
150. Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A, Maini MK. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008; 118: 1835-1845 [PMID: 18398508 DOI: 10.1172/JCI33402]